RAPT Therapeutics News

RAPT Therapeutics | 8-K: Current report

May 23 16:52 ET

RAPT Therapeutics | 8-K: RAPT Therapeutics Reports First Quarter 2024 Financial Results

May 9 08:07 ET

RAPT Therapeutics | DEFA14A: Others

Apr 5 16:15 ET

RAPT Therapeutics | DEF 14A: Definitive information statements

Apr 5 16:10 ET

RAPT Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 7 16:22 ET

RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 7 08:04 ET

RAPT Therapeutics | 8-K: Current report

Feb 22 17:18 ET

RAPT Therapeutics | 8-K: Current report

Feb 20 16:35 ET

RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Third Quarter 2023 Financial Results

Nov 13, 2023 08:03 ET

RAPT Therapeutics | 8-K: Current report

Nov 3, 2023 12:03 ET

RAPT Therapeutics | 8-K: Current report

Aug 11, 2023 16:02 ET

RAPT Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Aug 11, 2023 08:57 ET

RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Second Quarter 2023 Financial Results

Aug 11, 2023 08:05 ET

RAPT Therapeutics | 8-K: Current report

May 26, 2023 08:01 ET

RAPT Therapeutics | DEFA14A: Others

May 15, 2023 16:08 ET

RAPT Therapeutics | 8-K: RAPT Therapeutics Reports First Quarter 2023 Financial Results

May 11, 2023 08:10 ET

RAPT Therapeutics | DEFA14A: Others

Apr 7, 2023 12:20 ET

RAPT Therapeutics | DEF 14A: Definitive proxy statements

Apr 7, 2023 12:17 ET

RAPT Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 14, 2023 16:05 ET

RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Fourth Quarter And Year End Financial Results

Mar 14, 2023 08:05 ET